Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9921 |
Infliximab
|
TNF | Apoptosis |
Infliximab 是一种与 TNF-α特异性结合的嵌合单克隆 IgG1 抗体,可阻止 TNF-α与 TNFR1和 TNFR2 的相互作用,用于治疗克罗恩病和类风湿性关节炎。 | |||
T61111 |
UCB-5307
|
TNF | Apoptosis |
UCB-5307 是一种小分子化合物,可在体外抑制 TNFR1 信号转导和下游功能。 人 TNFα 的 KD 为 9 nM。 TNF 直接通过缓慢的结合动力学结合,KD = 6 nM。 UCB-5307 可以通过预制的 hTNF/hTNFR1 复合物。 | |||
T38361 |
GSK717
|
IL Receptor; NOD | Immunology/Inflammation; NF-κB |
GSK717 是 NOD2(核苷酸结合寡聚结构域 2) 的选择性抑制剂。它抑制壁酰二肽 (MDP) 诱导的 NOD2 介导的信号转导,抑制 MDP 刺激的 HEK293/hNOD2 细胞分泌 IL-8 (IC50为 400 nM)。 | |||
T68954 |
UCB-6876
|
||
UCB-6876 is a novel inhibitor of TNF signalling by stabilising an asymmetric form of the trimer, displaying a concentration-dependent response curve and selectivity over the TNFR1 extracellular domain and control proteins. | |||
T71807 |
UCB-6786
|
||
UCB-6786 is a novel inhibitor of TNF signalling by stabilising an asymmetric form of the trimer, displaying a concentration-dependent response curve and selectivity over the TNFR1 extracellular domain and control proteins. | |||
T80561 |
Atrosab
|
||
Atrosab是一种人源化IgG1抗TNFR1抗体,具有拮抗作用。它能够抑制TNF诱导的细胞凋亡(apoptosis),并减少IL-6和IL-8的生成,有助于研究炎症性疾病。 | |||
T27687 |
JNJ525
JNJ 525,JNJ-525 |
||
JNJ525 is an inhibitor of TNFα. JNJ525 inhibits protein function via an aggregation-based mechanism. JNJ525 prevents the formation of TNFα complexes with TNFR1 and TNFR2, the apparent IC50 values for the inhibition of complex formation are 1.2 ± 0.2 μM an | |||
T36097 | TNF-α-IN-2 | ||
TNF-α-IN-2 is a highly potent and orally bioavailable inhibitor of tumor necrosis factor alpha (TNFα), exhibiting an IC50 of 25 nM in the HTRF assay. It exerts its inhibitory effects by inducing conformational changes in the TNFα trimer upon binding, resulting in disrupted signaling when the trimer interacts with TNFR1. TNF-α-IN-2 holds promise as a valuable tool for investigating the pathogenesis of rheumatoid arthritis[1]. | |||
T36486 |
Benpyrine
|
||
Benpyrine is a highly specific and orally active TNF-α inhibitor with a KD value of 82.1 μM. Benpyrine tightly binds to TNF-α and blocks its interaction with TNFR1, with an IC50 value of 0.109 μM. Benpyrine has the potential for TNF-α mediated inflammatory and autoimmune disease research[1]. Benpyrine (5-20 μM; 14 hours; RAW264.7 cells) pretreatment results in a dose-dependent decrease in the phosphorylation of IκBα in RAW264.7 cells (stimulated with 10 ng/mL TNF-α or 1 μg/mL LPS). Benpyrine abo... | |||
T38263 |
TBK1/IKKε-IN-4
TBK1/IKKε-IN-4 |
||
TBK1/IKKε-IN-4 is a 6-aminopyrazolopyrimidine derivative and a potent, selective TBK1 and IKKε inhibitor with IC50 values of 13 nM and 59 nM, respectively. TBK1/IKKε-IN-4 shows 100- to 1000-fold less activity against other protein kinases including PDK1, PI3K family members and mTOR[1]. TBK1/IKKε-IN-4 (Compound II; 96 hours; A549 andHCC44 cells) treatmentdisplays selective toxicity in TBK1-dependent cancer cell lines (IC50 of ~ 4.2 μM for H441 cells and IC50 of ~0.4 μM for A549 cells)[1].TBK1/IK... |